USFDA issues one observation for Unichem's Ghaziabad formulations facility
"The United States Food and Drug Administration (USFDA) conducted inspection at the company's Ghaziabad formulation facility between August 19, 2019 to August 23, 2019. The inspection was a routine Good manufacturing practice (GMP) surveillance," Unichem said in a regulatory filing.